High-Purity (3S,4a,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinolin-3-carboxamide: Your Trusted Pharmaceutical Intermediate Supplier

Discover the critical role of (3S,4a,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinolin-3-carboxamide (CAS 136522-17-3) in advanced pharmaceutical synthesis. As a leading manufacturer and supplier, we provide high-quality, reliably sourced intermediates to accelerate your drug development projects. Explore our commitment to purity, consistency, and competitive pricing for your global pharmaceutical needs.

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediates

Uncompromising Quality and Purity

Our commitment to producing high-purity (3S,4a,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinolin-3-carboxamide ensures that your pharmaceutical formulations are built on a foundation of excellence. We understand the critical nature of API synthesis and guarantee that our chemical intermediates meet stringent specifications.

Stable Supply Chain and Competitive Pricing

As a reliable manufacturer and supplier based in China, we offer a stable and consistent supply of this vital pharmaceutical intermediate. Benefit from our competitive pricing structures, making high-quality chemical sourcing accessible for your R&D and manufacturing operations.

Expertise in Chiral Synthesis

Our specialization in chiral reagents and complex organic synthesis means we can confidently deliver precisely engineered molecules like CAS 136522-17-3. Trust our technical expertise to provide intermediates that facilitate the efficient development of advanced pharmaceuticals.

Key Applications in Pharmaceutical Development

Active Pharmaceutical Ingredient (API) Synthesis

This compound is instrumental in the synthesis of various Active Pharmaceutical Ingredients, demanding high purity and specific stereochemistry from its chemical supplier.

Drug Discovery and Development

Researchers in drug discovery rely on consistent access to novel and established intermediates to explore new therapeutic agents. We support this critical phase of pharmaceutical innovation.

Chiral Synthesis Building Block

Its well-defined chiral centers make it an essential building block for creating complex chiral molecules, crucial for many modern drug candidates.

Chemical Research and Innovation

Universities and research institutions utilize such intermediates in fundamental chemical research, driving forward scientific understanding and technological advancement in the field.